GlassScriptPhysician profile
Constance O Okeke
NPI 1851328132
$800,379.50
in general payments reported to CMS, 2019-2025
44 companies · $236K in 2025
The $236K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $94K · 2021: $72K · 2022: $48K · 2023: $121K · 2024: $145K · 2025: $236K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $142K · Consulting Fee: $109K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $103K · Grant: $86K · Travel and Lodging: $40K · Food and Beverage: $11K · Honoraria: $9,450 · Gift: $61.89 · Other payment types: $26.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $142,425.00 |
| Consulting Fee | $109,304.66 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $103,262.50 |
| Grant | $86,000.00 |
| Travel and Lodging | $39,874.32 |
| Food and Beverage | $11,230.62 |
| Honoraria | $9,450.00 |
| Gift | $61.89 |
| Other payment types | $26.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $167,203.11 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Abbvie INC. | $122,147.45 | 2022-2025 | |
| Alcon Vision LLC | $91,833.99 | 2019-2025 | Rhopressa, Rocklatan, Simbrinza |
| Sight Sciences, INC. | $87,316.90 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $82,974.14 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $78,791.50 | 2019-2021 | |
| Glaukos Corporation | $78,085.86 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idose, Idosetr |
| New World Medical,INC. | $18,819.74 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Microsurgical Technology, INC. | $13,000.00 | 2019-2021 | |
| Katena Products, INC. (Dba Corza Medical) | $12,562.50 | 2022 | |
| Allergan, INC. | $10,821.94 | 2019-2022 | |
| Nova Eye, INC. | $8,700.00 | 2021-2022 | |
| Akorn, INC. | $7,500.00 | 2020 | |
| Ellexiscience | $5,387.35 | 2019 | |
| Ocular Therapeutix, INC. | $2,649.81 | 2023-2025 | Dextenza |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reichert, INC. | $2,500.00 | 2019 | |
| Alcon Research LLC | $2,361.00 | 2022-2023 | |
| Regeneron Pharmaceuticals, INC. | $1,920.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $1,497.79 | 2019-2022 | |
| Ivantis, INC | $1,048.09 | 2020-2021 | |
| Thea Pharma INC. | $934.72 | 2022-2025 | Iyuzeh |
| Neomedix Corporation | $750.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $417.07 | 2019-2025 | Cequa, Xelpros |
| Mallinckrodt Hospital Products INC. | $230.14 | 2020-2025 | Acthar |
| Horizon Therapeutics Plc | $173.95 | 2022-2023 | Tepezza, Uplizna |
| Tarsus Pharmaceuticals, INC. | $155.14 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $99.10 | 2019 | |
| Rayner Intraocular Lenses Limited | $66.19 | 2023-2025 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Oyster Point Pharma, INC. | $56.16 | 2022-2023 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $54.36 | 2023-2025 | Eylea Hd |
| Amgen INC. | $41.28 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $36.37 | 2024 | |
| Dompe US, INC. | $34.90 | 2022 | |
| Harrow Eye, LLC | $33.31 | 2024 | Vevye |
| Apellis Pharmaceuticals, INC. | $26.66 | 2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $22.47 | 2025 | Iluvien |
| Lensar, INC. | $21.90 | 2019 | |
| Shire North American Group INC | $21.24 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $18.80 | 2022 | |
| Alimera Sciences, INC. | $17.42 | 2024 | Iluvien, Yutiq |
| Rxsight INC | $17.23 | 2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Merz North America, INC. | $15.06 | 2019 | |
| Notal Vision, INC. | $14.86 | 2025 | Foresee Home |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$48,575.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Okeke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.